ArticleCells2019

Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton's Jelly.

Marta Grau-Vorster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.